Founder Adello Biologics, LLC, (renamed from TPI), a fully integrated US biosimilars company with several products at FDA approval stages. Inducted into the Chicago Entrepreneur Hall of Fame for his entrepreneurial leadership, having raised over hundreds of millions of dollars, the largest such funding in the history for a biotechnology start up.
For over two decades, developing biosimilars, from cell line to market; including 351(k) filings. Wrote the book on biosimilars, bioprocessing, formulations and regulatory management. Now, a new proven model allows development at the fastest pace. Several molecules in advanced stages.
Professor of Biopharmaceutical Sciences, Adj., University of Illinois, University of Houston, HEJ Research Institute, and National University of Science and Technology; 45+ years, pharmaceutical sciences.
Largest holder of solo patents in bioprocessing technology in the world; 200+ inventions for NCEs, complex drug delivery systems, analytical testing, clinical applications, facility designs. and many more; millions of people around the globe using these inventions: awarded the
IP law Practitioner
Gratis service to scientists around the world; Freedom-to-operate opinions; prosecution of NCEs, drug delivery systems, biotechnology, computer technology, biodefense techniques, etc.
Pharmaceutical, biotechnology, botanical product, from design to market ( PharmSci®, a "novel solutions" company. Contributor to regulatory guidelines EMA, FDA, WHO, and several others.
The Forbes Magazine'smost interesting man in the world for his efforts in making high-cost drugs affordable across the globe; Wikipedia, The Chicago Tribune, Crain's Business, The Express, and Diagnostico Brazil, Alumnus of the Year by the University of Illinois. Voice of America (US State Department) radio host with audience into billions. Pakistan's highest civil award, Star of Distinction. An avid photographer, guitarist, and music composer. Lives in Illinois and Wisconsin.